Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research
- Author
- Joost Willebrords, Isabel Veloso Alves Pereira, Michaël Maes, Sara Crespo Yanguas, Isabelle Colle (UGent) , Bert Van Den Bossche, Tereza Cristina Da Silva, Cláudia Pinto Marques Souza de Oliveira, Wellington Andraus, Venâncio Avancini Alves, Bruno Cogliati and Mathieu Vinken
- Organization
- Keywords
- Non-alcoholic fatty liver disease, Steatosis, Models, Drugs, Biomarkers, MITOCHONDRIAL PERMEABILITY TRANSITION, CHOLINE-DEFICIENT DIET, EXACERBATES HEPATIC STEATOSIS, PRIMARY HUMAN HEPATOCYTES, GENE-EXPRESSION PROFILES, PRIMARY RAT HEPATOCYTES, CANNABINOID RECEPTOR 1, ZEBRAFISH DANIO-RERIO, BILE-ACID HOMEOSTASIS, VALPROIC ACID
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8563301
- MLA
- Willebrords, Joost, et al. “Strategies, Models and Biomarkers in Experimental Non-Alcoholic Fatty Liver Disease Research.” PROGRESS IN LIPID RESEARCH, vol. 59, 2015, pp. 106–25, doi:10.1016/j.plipres.2015.05.002.
- APA
- Willebrords, J., Pereira, I. V. A., Maes, M., Crespo Yanguas, S., Colle, I., Van Den Bossche, B., … Vinken, M. (2015). Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. PROGRESS IN LIPID RESEARCH, 59, 106–125. https://doi.org/10.1016/j.plipres.2015.05.002
- Chicago author-date
- Willebrords, Joost, Isabel Veloso Alves Pereira, Michaël Maes, Sara Crespo Yanguas, Isabelle Colle, Bert Van Den Bossche, Tereza Cristina Da Silva, et al. 2015. “Strategies, Models and Biomarkers in Experimental Non-Alcoholic Fatty Liver Disease Research.” PROGRESS IN LIPID RESEARCH 59: 106–25. https://doi.org/10.1016/j.plipres.2015.05.002.
- Chicago author-date (all authors)
- Willebrords, Joost, Isabel Veloso Alves Pereira, Michaël Maes, Sara Crespo Yanguas, Isabelle Colle, Bert Van Den Bossche, Tereza Cristina Da Silva, Cláudia Pinto Marques Souza de Oliveira, Wellington Andraus, Venâncio Avancini Alves, Bruno Cogliati, and Mathieu Vinken. 2015. “Strategies, Models and Biomarkers in Experimental Non-Alcoholic Fatty Liver Disease Research.” PROGRESS IN LIPID RESEARCH 59: 106–125. doi:10.1016/j.plipres.2015.05.002.
- Vancouver
- 1.Willebrords J, Pereira IVA, Maes M, Crespo Yanguas S, Colle I, Van Den Bossche B, et al. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. PROGRESS IN LIPID RESEARCH. 2015;59:106–25.
- IEEE
- [1]J. Willebrords et al., “Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research,” PROGRESS IN LIPID RESEARCH, vol. 59, pp. 106–125, 2015.
@article{8563301,
author = {{Willebrords, Joost and Pereira, Isabel Veloso Alves and Maes, Michaël and Crespo Yanguas, Sara and Colle, Isabelle and Van Den Bossche, Bert and Da Silva, Tereza Cristina and de Oliveira, Cláudia Pinto Marques Souza and Andraus, Wellington and Alves, Venâncio Avancini and Cogliati, Bruno and Vinken, Mathieu}},
issn = {{0163-7827}},
journal = {{PROGRESS IN LIPID RESEARCH}},
keywords = {{Non-alcoholic fatty liver disease,Steatosis,Models,Drugs,Biomarkers,MITOCHONDRIAL PERMEABILITY TRANSITION,CHOLINE-DEFICIENT DIET,EXACERBATES HEPATIC STEATOSIS,PRIMARY HUMAN HEPATOCYTES,GENE-EXPRESSION PROFILES,PRIMARY RAT HEPATOCYTES,CANNABINOID RECEPTOR 1,ZEBRAFISH DANIO-RERIO,BILE-ACID HOMEOSTASIS,VALPROIC ACID}},
language = {{eng}},
pages = {{106--125}},
title = {{Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research}},
url = {{http://doi.org/10.1016/j.plipres.2015.05.002}},
volume = {{59}},
year = {{2015}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: